PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol.23, no.4, pp.300-306, 2004 (SCI-Expanded)
Objective. To compare the immunogenicity and safety of a virosome-adjuvanted influenza vaccine (Inflexal V, Berna Biotech, Berne, Switzerland) and a split influenza vaccine (Fluarix; GlaxoSmithMine Biologicals, Rixensart, Belgium) in children.